» Authors » Philip N Britton

Philip N Britton

Explore the profile of Philip N Britton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 142
Citations 1418
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Burrell R, Saravanos G, Kesson A, Leung K, Outhred A, Wood N, et al.
PLoS One . 2025 Jan; 20(1):e0313504. PMID: 39841690
Acute respiratory infections cause significant paediatric morbidity, but for pathogens other than influenza, respiratory syncytial virus (RSV), and SARS-CoV-2, systematic monitoring is not commonly performed. This retrospective analysis of six...
2.
Koirala A, Smith K, Britton P, Howard-Jones A, Sintchenko V, Donnan E, et al.
J Infect Dis . 2025 Jan; PMID: 39785137
A prolonged tuberculosis outbreak, linked by whole-genome sequencing, occurred in a Pasifika extended family over 10 years (2013-2022) in Sydney, Australia. Despite Australia's low tuberculosis incidence, social and cultural complexities,...
3.
Berkhout A, Clark J, Jones C, Grimwood K, McMullan B, Britton P, et al.
J Antimicrob Chemother . 2024 Nov; 80(2):354-362. PMID: 39556200
Background: Variations in neonatal aciclovir prescribing for suspected herpes simplex virus (HSV) disease are well-known, but there are limited data describing aciclovir prescribing in older children. Methods: Medical records of...
4.
Ozturk A, Chan M, Khan J, Hu N, McMullan B, Britton P, et al.
J Infect Dis . 2024 Nov; PMID: 39484989
Background: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections (ALRIs) associated hospitalisations in children. It is unclear if hospitalized RSV-ALRI differs in clinically from other...
5.
Mazzocato P, Leder K, Deng L, Britton P
Public Health Res Pract . 2024 Oct; 34(3). PMID: 39443094
Study Type: Observational cohort study. Methods: In the 18 months immediately before the COVID-19 pandemic (2018-2020), we prospectively collected demographic, travel and clinical data from children with travel-acquired illness or...
6.
Campbell A, Russell F, Marais B, Britton P, Bowen A, Blyth C, et al.
Lancet Reg Health West Pac . 2024 Sep; 51:101205. PMID: 39328247
No abstract available.
7.
Koirala A, McRae J, Britton P, Downes M, Prasad S, Nicholson S, et al.
PLoS One . 2024 Sep; 19(9):e0300555. PMID: 39292730
Background: Following reduction of public health and social measures concurrent with SARS-CoV-2 Omicron emergence in late 2021 in Australia, COVID-19 case notification rates rose rapidly. As rates of direct viral...
8.
Britton P, Burrell R, Chapman E, Boyle J, Alexander S, Belessis Y, et al.
Pediatr Res . 2024 Aug; PMID: 39215197
Background: Pediatric long COVID remains incompletely understood with scant Australian data available. We aimed to assess the impacts of the 2021 Delta variant of SARS-CoV-2 outbreak on symptoms and functioning...
9.
Campbell A, Anpalagan K, Best E, Britton P, Gwee A, Hatcher J, et al.
JAMA Pediatr . 2024 Aug; 178(10):1066-1071. PMID: 39158898
Importance: There is a recognized unmet need for clinical trials to provide evidence-informed care for infants, children and adolescents. This Special Communication outlines the capacity of 3 distinct trial design...
10.
Wen S, Harris P, Forde B, Permana B, Chatfield M, Lau C, et al.
Clin Infect Dis . 2024 Jun; 79(3):734-743. PMID: 38917034
Background: Gram-negative bloodstream infections (GNBSIs) more commonly occur in children with comorbidities and are increasingly associated with antimicrobial resistance. There are few large studies of GNBSIs in children that relate...